- €7.65bn
- €18.65bn
- €7.52bn
Brief: Grifols Approves Interim Dividend Of €0.15/Shr Payable On Dec 4
Brief: Grifols Q3 Group Profit €162 Mln
Refile: Grifols says Canada plasma license suspension has no impact on ongoing operations
Brief: Health Canada Suspends Licence Of Grifols Site In Winnipeg - Globe And Mail
Brief: Grifols Strengthens Evidence For AMBAR In Alzheimer's With RWE Data
Brief: Grifols Signs 10-Year Renewable Energy Supply Deal With ENGIE In Spain
Press Digest: Canada - August 19
Brief: Kedrion Biopharma Announces The Extension Of A U.S. Agreement With Grifols To Support Long-Term And Continued Access To Gammaked®
Spanish stocks - Factors to watch on July 31
Spanish stocks - Factors to watch on July 29
Brief: Grifols H1 Net Profit €227.5 Mln
Spanish stocks - Factors to watch on July 27
Brief: Grifols Doses First Patients In Two Phase 3 Trials To Expand Indications Of Immunoglobulins
Spanish stocks - Factors to watch on July 1
Brief: Grifols Reorganizes Operating Model, Creates Separate U.S. And Rest-Of-World Biopharma Units
Spanish stocks - Factors to watch on June 24
Brief: Grifols Approves Reduction Of Up To 10% Of Its Share Capital
Brief: Grifols Launches Fibrinogen Concentrate For Acute Bleeding Episodes In The U.S.
Brief: Grifols' Egypt Unit Adds €180 Mln Of Additional Investment In Project